Circulating microRNAs as potential biomarkers for diagnosis of congenital heart defects.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  World Journal of Emergency Medicine

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.5847/wjem.j.1920-8642.2016.02.001PMID 27313801PMCID PMC4905874
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prenatal diagnosis of congenital heart defects: accuracy and discrepancies in a multicenter cohort

  2016cited by this paper
• Circulating MicroRNAs: Potential and Emerging Biomarkers for Diagnosis of Cardiovascular and Cerebrovascular Diseases

  2015cited by this paper
• MicroRNAs as potential biomarkers for noninvasive detection of fetal trisomy 21

  2015cited by this paper
• Fetal echocardiography for congenital heart disease diagnosis: a meta-analysis, power analysis and missing data analysis

  2015cited by this paper
• Long noncoding RNAs and microRNAs in cardiovascular pathophysiology.

  2015cited by this paper
• Screening and identification of potential predictive biomarkers for Down’s syndrome from second trimester maternal serum

  2015cited by this paper
• Circulating MicroRNAs as Clinical Biomarkers in the Predictions of Pregnancy Complications

  2015cited by this paper
• Utility of Circulating MicroRNAs as Clinical Biomarkers for Cardiovascular Diseases

  2015cited by this paper
• Current State of Circulating MicroRNAs as Cancer Biomarkers.

  2015cited by this paper
• MicroRNA-421 Dysregulation is Associated with Tetralogy of Fallot

  2014cited by this paper
• miRNA-940 reduction contributes to human Tetralogy of Fallot development

  2014cited by this paper
• The impact of noninvasive fetal evaluation: its effect on education, training, and the maintenance of clinical competence in prenatal diagnosis

  2014cited by this paper
• De Novo Mutations in Histone-Modifying Genes in Congenital Heart Disease Congenital Heart Disease Entering a New Era of Human Genetics Commentaries on Cutting Edge Science

  2014cited by this paper
• Characterization of Circulating MicroRNA Expression in Patients with a Ventricular Septal Defect

  2014cited by this paper
• A new marker set that identifies fetal cells in maternal circulation with high specificity

  2014cited by this paper
• MiR-10a and MiR-10b Target the 3′-Untranslated Region of TBX5 to Repress Its Expression

  2014cited by this paper
• Diversifying microRNA sequence and function

  2013cited by this paper
• Signature MicroRNA expression patterns identified in humans with 22q11.2 deletion/DiGeorge syndrome.

  2013cited by this paper
• MicroRNA deregulation in right ventricular outflow tract myocardium in nonsyndromic tetralogy of fallot.

  2013cited by this paper
• Circulating microRNA expression profile and systemic right ventricular function in adults after atrial switch operation for complete transposition of the great arteries

  2013cited by this paper
• miR-138 protects cardiomyocytes from hypoxia-induced apoptosis via MLK3/JNK/c-jun pathway.

  2013cited by this paper
• Clinical and socioeconomic predictors of pregnancy termination for fetuses with congenital heart defects: a population‐based evaluation

  2013cited by this paper
• Identification of maternal serum microRNAs as novel non-invasive biomarkers for prenatal detection of fetal congenital heart defects.

  2013cited by this paper
• Roles of miR-1-1 and miR-181c in ventricular septal defects.

  2013cited by this paper
• Noncoding RNA Expression in Myocardium From Infants With Tetralogy of Fallot

  2012cited by this paper
• Earlier surgical intervention in congenital heart disease results in better outcome and resource utilization

  2011cited by this paper
• microRNA expression profiling in fetal single ventricle malformation identified by deep sequencing.

  2011cited by this paper
• Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.

  2011cited by this paper
• Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

  2009cited by this paper
• The developmental genetics of congenital heart disease

  2008cited by this paper
• Detection and characterization of placental microRNAs in maternal plasma.

  2008cited by this paper
• The incidence of congenital heart disease.

  2002cited by this paper
• Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4

  1996cited by this paper

• Identification of miR-20b-5p as an inhibitory regulator in cardiac differentiation via TET2 and DNA hydroxymethylation

  2024cites this paper
• Exosomes and miRNAs in Cardiovascular Diseases and Transcatheter Pulmonary Valve Replacement: Advancements, Gaps and Perspectives

  2024cites this paper
• MicroRNAs in chronic pediatric diseases (Review)

  2024cites this paper
• Diet and miRNA: Epigenetic Regulator or a New Class of Supplements?

  2022cites this paper
• The Role of Cell-Free Fetal DNA as a Preventative Attempt to Decrease the Severity of Genetic Disorders: A Review

  2021cites this paper
• Extracellular Vesicles in Premature Aging and Diseases in Adulthood Due to Developmental Exposures

  2021cites this paper
• The role of DNA methylation in syndromic and non-syndromic congenital heart disease

  2021cites this paper
• Association analysis of maternal MTHFR gene polymorphisms and the occurrence of congenital heart disease in offspring

  2021cites this paper
• Congenital heart diseases: genetics, non-inherited risk factors, and signaling pathways

  2020cites this paper
• Clinical application of exosomes and circulating microRNAs in the diagnosis of pregnancy complications and foetal abnormalities

  2020cites this paper
• Altered microRNA and target gene expression related to Tetralogy of Fallot

  2019cites this paper
• MicroRNAs and Congenital Heart Disease: Where Are We Now?

  2019influential citation
• El papel de los microARN en las cardiopatías congénitas: qué sabemos

  2019cites this paper
• DGCR8 expression is altered in children with congenital heart defects.

  2019cites this paper
• Preventing and Diagnosing Diabetic Complications: Epigenetics, miRNA, DNA Methylation, and Histone Modifications

  2019cites this paper
• Prenatal maternal biomarkers for the early diagnosis of congenital malformations: A review

  2019cites this paper
• Navigating the non-coding genome in heart development and Congenital Heart Disease.

  2019cites this paper
• The role of microRNAs in congenital heart disease

  2019cites this paper
• Epigenetics and Mechanobiology in Heart Development and Congenital Heart Disease

  2019cites this paper
• Applications of miRNA, DNA methylation, and histone modifications on diagnosis and therapeutics of diabetic embryopathy

  2019cites this paper
• POSTTRANSCRIPTIONAL REGULATION IN CONGENITAL HEART DISEASE: THE ROLE OF miRNA

  2019cites this paper
• Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital

  2018cites this paper
• Noninvasive prenatal testing for congenital heart disease – cell-free nucleic acid and protein biomarkers in maternal blood

  2018cites this paper
• Epigenetics for the pediatric cardiologist

  2017cites this paper
• Maternal plasma miRNAs as biomarkers during mid-pregnancy to predict later spontaneous preterm birth: a pilot study

  2017cites this paper
• Genetics of Congenital Heart Disease: Past and Present

  2016cites this paper